PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20404549-0	2010	Effects of vatalanib on tumor growth can be potentiated by mTOR blockade in vivo.	vatalanib	11-20	mechanistic target of rapamycin kinase	Homo sapiens	59-63	
24685058-1	2014	BACKGROUND: Vatalanib is an oral vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI), whereas everolimus inhibits mammalian target of rapamycin (mTOR).	vatalanib	12-21	mechanistic target of rapamycin kinase	Homo sapiens	177-181